Arkolith/Funds/Venrock Adviser, LLC

Venrock Adviser, LLC

CIK 1615982Hedge fund
Holdings as of Mar 31, 2026·disclosed May 15, 2026·~45-day 13F lag·13F-HR
Active Filer

Venrock Adviser, LLC holds a focused book of 33 stocks worth $2.7B as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened Damora Therapeutics Inc and trimmed Erasca Inc. Their largest long position is Apogee Therapeutics Inc at 27% of the equity book.

Build

Build on this 13F portfolio

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp
Build

Ask your agent what Venrock Adviser, LLC owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Get a key Compare plans13F data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/1615982/holdings"
Ask your agent
Use Arkolith to show Venrock Adviser, LLC's latest
holdings, largest changes, and filing provenance.
Opened
8
new positions
Added to
6
existing
Trimmed
6
reduced
Sold out
2
exited

Concentration

Top-heavy: focused book

Top 5 holdings
56%
Top 10 holdings
72%
Top 20 holdings
91%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Direct sector allocation

99% mapped to company sectors

Health Care
99%
ETF / fund or unclassified
1%

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices, no cost basis

Bought
Trimmed / exited

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

33 positions
#SecurityValueShares% PortLast moveHistory
1
COM
$714.9M8.49M
26.7%
—Held
2
COM
$265.1M16.38M
9.9%
▼−8.3%
Reduced · −1.5M sh
3
COM
$203.5M4.15M
7.6%
—Held
4
COM NEW
$185.9M3.69M
6.9%
—Held
5
COM
$130.3M6.47M
4.9%
▼−3.8%
Reduced · −255K sh
6
COM
$99.0M1.18M
3.7%
▲+18%
Added · +180K sh
7
COM NEW
$93.3M3.60M
3.5%
▲New
New position
8
COM
$87.6M10.35M
3.3%
▲+41%
Added · +3.0M sh
9
COM
$77.0M2.00M
2.9%
—Held
10
COM
$75.9M3.88M
2.8%
—Held
11
COM
$75.0M13.74M
2.8%
—Held
12
COM
$67.7M1.73M
2.5%
▼−46%
Reduced · −1.5M sh
13
COM
$54.7M4.32M
2.0%
▼−24%
Reduced · −1.4M sh
14
COM NEW
$54.3M3.04M
2.0%
▲+56%
Added · +1.1M sh
15
COM
$47.8M1.60M
1.8%
▲+3.5%
Added · +53K sh
16
COM
$46.9M9.98M
1.8%
▼−36%
Reduced · −5.6M sh
17
COM NEW
$45.2M3.22M
1.7%
—Held
18
COM
$39.4M2.17M
1.5%
—Held
19
COM
$39.2M2.13M
1.5%
—Held
20
CLASS A ORD SHS
$38.3M6.43M
1.4%
▲+20%
Added · +1.1M sh
21
COM
$33.7M4.84M
1.3%
▲New
New position
22
COM
$32.5M4.77M
1.2%
—Held
23
COM NEW
$26.8M1.68M
1.0%
▲New
New position
24
SPONSORED ADS
$22.2M3.21M
0.8%
▲New
New position
25
COM
$19.7M8.70M
0.7%
▲New
New position
26
COM
$19.6M1.38M
0.7%
—Held
27
COM NEW
$18.5M3.85M
0.7%
▲+0.3%
Added · +11K sh
28
COM NEW
$18.4M632.9K
0.7%
—Held
29
COM
$12.2M506.1K
0.5%
▼−17%
Reduced · −105K sh
30
COM
$11.4M1.01M
0.4%
▲New
New position
31
COM SHS
$11.2M500.0K
0.4%
▲New
New position
32
COM
$10.4M1.61M
0.4%
—Held
33
COM NEW
$1.4M330.5K
0.1%
▲New
New position
Showing all 33 positions

Filing history

As-of date vs the date the SEC received each filing

QuarterAs ofFiledPositionsValueForm
Q1 2026Mar 31, 2026May 15, 202633$2.7B13F-HR
Q4 2025Dec 31, 2025Feb 17, 202627$2.0B13F-HR
Q3 2025Sep 30, 2025Nov 14, 202533$1.8B13F-HR
Q2 2025Jun 30, 2025Aug 14, 202531$1.3B13F-HR
Q1 2025Mar 31, 2025May 15, 202537$1.2B13F-HR
Q4 2024Dec 31, 2024Feb 14, 202537$1.5B13F-HR
Q3 2024Sep 30, 2024Nov 14, 202438$1.9B13F-HR
Q2 2024Jun 30, 2024Aug 14, 202435$1.6B13F-HR
Q1 2024Mar 31, 2024May 15, 202438$2.1B13F-HR
Q4 2023Dec 31, 2023Feb 14, 202436$1.5B13F-HR
Q3 2023Sep 30, 2023Nov 14, 202337$949.9M13F-HR
Q2 2023Jun 30, 2023Aug 11, 202330$625.4M13F-HR
Q1 2023Mar 31, 2023May 15, 202325$512.2M13F-HR
Q4 2022Dec 31, 2022May 15, 202328$593.6M13F-HR/A
Q3 2022Sep 30, 2022May 15, 202331$648.1M13F-HR/A
Q2 2022Jun 30, 2022May 15, 202327$507.8M13F-HR/A
Q1 2022Mar 31, 2022May 16, 202227$617.2M13F-HR
Q4 2021Dec 31, 2021Feb 14, 202226$731.5M13F-HR
Q3 2021Sep 30, 2021Nov 15, 202126$778.5M13F-HR
Q2 2021Jun 30, 2021Aug 13, 202129$824.4M13F-HR
Q1 2021Mar 31, 2021May 14, 202128$921.8M13F-HR
Amended / restated
  • Q4 2022 · filed Feb 14, 202313F-HR · superseded
  • Q3 2022 · filed Nov 14, 202213F-HR · superseded
  • Q2 2022 · filed Aug 15, 202213F-HR · superseded

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.